TrialThe European respiratory journal2022
Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trial.
Kevin R Flaherty et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
59 papers cite it
this paperpooled ittrialcites it